Literature DB >> 30794427

Correlation analysis between the SUVmax of FDG-PET/CT and clinicopathological characteristics in oral squamous cell carcinoma.

Dong Zheng1, Lixuan Niu2, Wenpeng Liu3, Changgang Zheng4, Ruyi Yan1, Liyan Gong1, Zhongxing Dong1, Ke Li1, Jun Fei1.   

Abstract

OBJECTIVES: : To investigate the relationship between maximum standardized uptake value (SUVmax) of 18F-FDG PET/CT and clinicopathological features of oral squamous cell carcinoma (OSCC), in order to formulate a better clinical guideline.
METHODS: : In 104 patients with OSCC confirmed by pathology, there were 67 males and 37 females (age, 33-76 years; mean age, 56 years).18FDG, 18-fludeoxyglucose (18F-FDG) PET/CT manifestations and the clinicopathological features of the 104 patients were retrospectively analysed. Single-factor analysis and multiple regression analysis were conducted on possible factors influencing primary tumour SUVmax, including gender, age, smoking history, tumour location, tumour size, histological differentiation, TNM stage, T stage, N stage. Diagnostic performance of SUVmax for invading peri-tissue of OSCC was measured by the area under receiver operating characteristic curve, and sensitivity and specificity were determined at the Youdons index.
RESULTS: : The single-analysis results showed that SUVmax was correlated with the histological differentiation, tumour size, TNM stage, T stage, N stage(p < 0.05), yet it was not correlated with gender, age, smoking history, tumour location (p > 0.05). Multivariate liner regression analysis showed that tumour size, TNM stage were influencing factors independent of primary tumour SUVmax (p < 0.05). Primary tumour SUVmax had predictive value for invading peri-tissue of OSCC. When the cutoff value was 7.98, the diagnostic efficiency was the highest, with the sensitivity being 90.0% and the specificity being 76.2%.
CONCLUSIONS: : OSCC 18F-FDG PET/CT SUVmax is higher among patients with larger tumour size, poorer stage, and that primary tumour SUVmax is of important significance in predicting invading peri-tissue.

Entities:  

Keywords:  F-FDG; Oral squamous cell carcinoma; PET and CT; standardized uptake value

Mesh:

Substances:

Year:  2019        PMID: 30794427      PMCID: PMC6747416          DOI: 10.1259/dmfr.20180416

Source DB:  PubMed          Journal:  Dentomaxillofac Radiol        ISSN: 0250-832X            Impact factor:   2.419


  14 in total

1.  Prognostic significance of SUVmax (maximum standardized uptake value) measured by [¹⁸F]FDG PET/CT in endometrial cancer.

Authors:  Kazuhiro Kitajima; Masato Kita; Kayo Suzuki; Michio Senda; Yuji Nakamoto; Kazuro Sugimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02-17       Impact factor: 9.236

2.  Noninvasive Differential Diagnosis of Pulmonary Nodules Using the Standardized Uptake Value Index.

Authors:  Satoshi Shiono; Naoki Yanagawa; Masami Abiko; Toru Sato
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-03-16       Impact factor: 1.520

3.  FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET).

Authors:  Salvatore Annunziata; Annarosa Cuccaro; Maria Chiara Tisi; Stefan Hohaus; Vittoria Rufini
Journal:  Ann Nucl Med       Date:  2018-02-20       Impact factor: 2.668

4.  FDG-PET/CT for diagnosis of primary ovarian cancer.

Authors:  Kazuhiro Kitajima; Kayo Suzuki; Michio Senda; Masato Kita; Yuji Nakamoto; Yumiko Onishi; Tetsuo Maeda; Takeshi Yoshikawa; Yoshiharu Ohno; Kazuro Sugimura
Journal:  Nucl Med Commun       Date:  2011-07       Impact factor: 1.690

5.  The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer.

Authors:  Keiichiro Nakamura; Junichi Kodama; Yoshihiro Okumura; Atsushi Hongo; Susumu Kanazawa; Yuji Hiramatsu
Journal:  Int J Gynecol Cancer       Date:  2010-01       Impact factor: 3.437

6.  Cancer statistics in China, 2015.

Authors:  Wanqing Chen; Rongshou Zheng; Peter D Baade; Siwei Zhang; Hongmei Zeng; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  CA Cancer J Clin       Date:  2016-01-25       Impact factor: 508.702

7.  Preoperative evaluation of oral tongue squamous cell carcinoma with intraoral ultrasound and magnetic resonance imaging-comparison with histopathological tumour thickness and accuracy in guiding patient management.

Authors:  A Yesuratnam; D Wiesenfeld; A Tsui; T A Iseli; S V Hoorn; M T Ang; A Guiney; P M Phal
Journal:  Int J Oral Maxillofac Surg       Date:  2014-03-02       Impact factor: 2.789

8.  MR lymphography for sentinel lymph node detection in patients with oral cavity cancer: Preliminary clinical study.

Authors:  Sohi Bae; Ho-Joon Lee; Woong Nam; Yoon Woo Koh; Eun Chang Choi; Jinna Kim
Journal:  Head Neck       Date:  2018-04-06       Impact factor: 3.147

9.  Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using 18F-FDG PET/CT.

Authors:  Lucas Goense; Jelle P Ruurda; Brett W Carter; Penny Fang; Linus Ho; Gert J Meijer; Richard van Hillegersberg; Wayne L Hofstetter; Steven H Lin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-16       Impact factor: 9.236

10.  CT evaluation of underlying bone sclerosis in patients with oral squamous cell carcinoma: A preliminary retrospective study.

Authors:  Gyu-Dong Jo; Won-Jin Yi; Min-Suk Heo; Sam-Sun Lee; Soon-Chul Choi; Kyung-Hoe Huh
Journal:  Imaging Sci Dent       Date:  2017-12-12
View more
  2 in total

1.  Implications of Standardized Uptake Values of Oral Squamous Cell Carcinoma in PET-CT on Prognosis, Tumor Characteristics and Mitochondrial DNA Heteroplasmy.

Authors:  Lukas Latzko; Bernd Schöpf; Hansi Weissensteiner; Federica Fazzini; Liane Fendt; Eberhard Steiner; Emanuel Bruckmoser; Georg Schäfer; Roy-Cesar Moncayo; Helmut Klocker; Johannes Laimer
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

2.  Clinical Significance and Prognostic Value of the Maximum Standardized Uptake Value of 18F-Flurodeoxyglucose Positron Emission Tomography-Computed Tomography in Colorectal Cancer.

Authors:  Yi-Xin Yin; Ming-Zhi Xie; Xin-Qiang Liang; Meng-Ling Ye; Ji-Lin Li; Bang-Li Hu
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.